Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blood-based transcriptomic biomarkers for response to [177Lu]Lu-DOTA-TATE therapy in neuroendocrine tumors. | EJNMMI Res | 2025 | 40753362 | PubTator, text mining | PubMed |
| Detection of Somatostatin Receptors by Ligand Derivative Staining in Breast Tumors. | Anticancer Res | 2025 | 40750409 | PubTator, text mining | PubMed |
| Well-Differentiated Lung Neuroendocrine Tumor Masquerading as Metastatic Medullary Thyroid Cancer. | JCEM Case Rep | 2025 | 40746501 | PubTator, text mining | PubMed |
| Differences in the expression of CMTM3 and SSTR2 genes in right and left colon tumors: A molecular insight into colorectal cancer. | Med Oncol | 2025 | 40720052 | PubTator, text mining | PubMed |
| Dopamine receptor expression predicts cabergoline response in persistent somatotroph adenoma. | Pituitary | 2025 | 40702399 | PubTator, text mining | PubMed |
| Enhancing Diagnostic Accuracy in Sinonasal Neuroendocrine Tumors: The Case for DOTATATE PET Over FDG PET. | Int Forum Allergy Rhinol | 2025 | 40679114 | PubTator, text mining | PubMed |
| Naphthalene-containing octreotide radioligand elevates selectivity and radionuclide therapy for somatostatin receptor 2-positive tumor. | Colloids Surf B Biointerfaces | 2025 | 40663863 | PubTator, text mining | PubMed |
| Somatostatin receptor expression in multiple hemangiomas. | Discov Oncol | 2025 | 40638034 | PubTator, text mining | PubMed |
Comparison of radiolabeled somatostatin analogs (DOTATATE, DOTANOC, and DOTATOC) in somatostatin receptor (SSTR) imaging for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a narrative literature review. | Ann Nucl Med | 2025 | 40580373 | PubTator, text mining | PubMed |
| Multimodal Model for Non-Invasive Detection of DRD2, SSTR2 and ESR1 Receptor Profiling in Pituitary Neuroendocrine Tumors: A Retrospective Study. | Technol Cancer Res Treat | 2025 | 40551554 | PubTator, text mining | PubMed |
| Comparison of clinicopathological characteristics and survival outcomes between solitary and multiple rectal neuroendocrine tumors: a propensity score-matched study. | Front Oncol | 2025 | 40538845 | PubTator, text mining | PubMed |
| Somatostatin receptor 2 targeting peptide modifications for peptide-drug conjugate treatment of small cell lung cancer. | Acta Pharmacol Sin | 2025 | 40533489 | PubTator, text mining | PubMed |
| Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells. | Theranostics | 2025 | 40521188 | PubTator, text mining | PubMed |
| Progressive microneedles for targeting and intelligent drug delivery. | Asian J Pharm Sci | 2025 | 40503059 | PubTator, text mining | PubMed |
| miR-375 Regulation of SSTR2 Expression in Corticotroph Pituitary Cells: Somatostatin Receptor Ligands Effects. | Endocrinology | 2025 | 40488558 | PubTator, text mining | PubMed |
| Genome-Wide Study of Diabetes Mellitus (Type 2)-Associated Genes in Homo sapiens (Human). | J Gene Med | 2025 | 40462586 | PubTator, text mining | PubMed |
| NOTA and NODAGA Radionuclide Complexing Agents: Versatile Approaches for Advancements in Radiochemistry. | Molecules | 2025 | 40430268 | PubTator, text mining | PubMed |
| Are epigenetic-targeting approaches ready for prime time in neuroendocrine neoplasms? | Curr Opin Oncol | 2025 | 40422736 | PubTator, text mining | PubMed |
| Emerging innovations in theranostics for pancreatic neuroendocrine tumors. | NPJ Precis Oncol | 2025 | 40389624 | PubTator, text mining | PubMed |
| SSTR2 exhibits a positive correlation with PD-L1 and predicts poor prognosis in nasopharyngeal carcinoma. | Int Immunopharmacol | 2025 | 40373596 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=10